Ziegler Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-23,411
Closed -$1.91M 409
2023
Q4
$1.91M Sell
23,411
-678
-3% -$52.8K 0.09% 227
2023
Q3
$1.81M Sell
24,089
-1,887
-7% -$145K 0.07% 225
2023
Q2
$2M Buy
25,976
+141
+0.5% +$11.2K 0.08% 228
2023
Q1
$2.15M Buy
25,835
+1,078
+4% +$89.3K 0.08% 212
2022
Q4
$2.13M Sell
24,757
-53
-0.2% -$4.2K 0.09% 210
2022
Q3
$1.55M Sell
24,810
-4,196
-14% -$265K 0.07% 232
2022
Q2
$1.79M Buy
29,006
+1,229
+4% +$76.1K 0.07% 229
2022
Q1
$1.67M Sell
27,777
-9,398
-25% -$601K 0.07% 227
2021
Q4
$2.7M Buy
37,175
+4,082
+12% +$281K 0.1% 210
2021
Q3
$2.31M Buy
33,093
+22,611
+216% +$1.59M 0.08% 223
2021
Q2
$722K Sell
10,482
-821
-7% -$54.8K 0.02% 362
2021
Q1
$731K Sell
11,303
-47,589
-81% -$3.07M 0.02% 362
2020
Q4
$3.43M Sell
58,892
-25,430
-30% -$1.53M 0.11% 211
2020
Q3
$5.33M Buy
84,322
+1,758
+2% +$122K 0.21% 175
2020
Q2
$6.35M Sell
82,564
-99,091
-55% -$7.59M 0.2% 167
2020
Q1
$13.6M Buy
+181,655
New +$12.6M 0.36% 74
2013
Q3
$7.06M Sell
112,353
-5,186
-4% -$310K 0.62% 42
2013
Q2
$6.03M Buy
+117,539
New +$6.13M 0.64% 35

Other funds holding GILD

Ziegler Capital Management's GILD Position: Q1 2024 in Review

Ziegler Capital Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 23,411 shares — an estimated $1.91M sold.

Ziegler Capital Management first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $13.6M in Q1 2020. 1,722 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Ziegler Capital Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Ziegler Capital Management sold 23,411 Gilead Sciences shares in Q1 2024, an estimated $1.91M.
  • Ziegler Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
  • Ziegler Capital Management's Gilead Sciences position peaked at $13.6M in Q1 2020.
  • 1,722 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Ziegler Capital Management's 13F filing for Q1 2024, filed 15 May 2024.